Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Lois La Grenade"'
Publikováno v:
Therapeutic Advances in Drug Safety, Vol 10 (2019)
Background: Intense pruritus or itching emerging after discontinuation of cetirizine has been the subject of postmarketing reports submitted to the U.S. Food and Drug Administration (FDA), published in the medical literature, and discussed on the int
Externí odkaz:
https://doaj.org/article/230eed47061c4df09706d9ec2eac1e2c
Autor:
Justin Bohn, Adebola O. Ajao, Efe Eworuke, Casie Horgan, Lois La Grenade, Monica A. Muñoz, Veronica Sansing-Foster, Mohamed Mohamoud, Elizabeth C. Dee, Danijela Stojanovic, Oren Shapira
Publikováno v:
Pharmacotherapy
Background Cutaneous small vessel vasculitis (CSVV) has been reported after exposure to direct oral anticoagulants (DOACs), such as dabigatran, rivaroxaban, apixaban, and edoxaban. Objective We used the U.S. Food and Drug Administration Adverse Event
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b69d83525107f6370edc39f85c8e1b83
https://pubmed.ncbi.nlm.nih.gov/33090530
https://pubmed.ncbi.nlm.nih.gov/33090530
Publikováno v:
SKIN The Journal of Cutaneous Medicine. 1:112-116
Purpose: Describe our review of the occurrence of acute generalized exanthematous pustulosis (AGEP) with hydroxyzine, and its active metabolites, cetirizine, and levocetirizine.Methods: The Division of Pharmacovigilance of the Food and Drug Administr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a98a9f5538df135565276a2ac0358ba
https://doi.org/10.25251/skin.1.3.1
https://doi.org/10.25251/skin.1.3.1
Publikováno v:
J Pediatr
Objective To identify and characterize cases of chemical leukoderma, an underrecognized adverse event, associated with the methylphenidate transdermal system (MTS) reported to the US Food and Drug Administration Adverse Event Reporting System (FAERS)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::991c85dfc73c14bfc7988e1ed4849e27
https://doi.org/10.1016/j.jpeds.2016.09.008
https://doi.org/10.1016/j.jpeds.2016.09.008
Publikováno v:
Therapeutic Advances in Drug Safety
Therapeutic Advances in Drug Safety, Vol 10 (2019)
Therapeutic Advances in Drug Safety, Vol 10 (2019)
Background: Intense pruritus or itching emerging after discontinuation of cetirizine has been the subject of postmarketing reports submitted to the U.S. Food and Drug Administration (FDA), published in the medical literature, and discussed on the int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13ff9f4b0fdf02731e71e8fea512f175
http://europepmc.org/articles/PMC6613055
http://europepmc.org/articles/PMC6613055
Publikováno v:
Advances in Diagnosis and Management of Cutaneous Adverse Drug Reactions ISBN: 9789811314889
The mainstay of pharmacosurveillance for cADRs is pharmacovigilance using passive surveillance systems such as the US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) and the World Health Organization’s (WHO) VigiBase®, wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d60dd7ebad11c0bb610a52ea66adf8c
https://doi.org/10.1007/978-981-13-1489-6_19
https://doi.org/10.1007/978-981-13-1489-6_19
Autor:
Rika Yuliwulandari, Lisa M. Wheatley, Andrea D. Dalton, Carolyn M. Hutter, Surakameth Mahasirimongkol, J. Steven Leeder, Simone P. Pinheiro, Teri A. Manolio, Ricardo Cibotti, Lauren A. Trepanier, Juan J.L. Lertora, Howard L. McLeod, Ming Ta Michael Lee, Cynthia Sung, Joshua C. Denny, Elizabeth J. Phillips, Mark I. Avigan, Michael Pacanowski, Lois La Grenade, Wen-Hung Chung, Neil H. Shear, Wimon Suwankesawong, Maja Mockenhaupt, Santa J. Tumminia, Mary Carrington, Robert L. Davis, Wasun Chantratita, Shuen-Iu Hung, David L. Veenstra, Munir Pirmohamed
Publikováno v:
CLINICAL PHARMACOLOGY & THERAPEUTICS
Stevens–Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is one of the most devastating of adverse drug reactions (ADRs) and was, until recently, essentially unpredictable. With the discovery of several risk alleles for drug-induced SJS/TEN an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c46764cf206365c5f1e504b7c397a6d4
https://europepmc.org/articles/PMC5805563/
https://europepmc.org/articles/PMC5805563/
Autor:
Munir Pirmohamed, Jeff Struewing, Andrea Sukhov, Emanual Michael Maverakis, Elizabeth A. Wang, Lars E. French, Surakameth Mahasirimongkol, David J. Margolis, Robert G. Micheletti, Neil H. Shear, Jennifer L. Goldman, Mark I. Avigan, Michelle Y. Cheng, Kanade Shinkai, Wen-Hung Chung, Ticha Rerkpattanapipat, Sally Usdin Yasuda, Lois La Grenade, Victoria R. Sharon, Wichittra Tassaeeyakul, Wolfram Hoetzenecker, Wiparat Manuyakorn, Jettanong Klaewsongkram
Publikováno v:
JAMA DERMATOLOGY
Importance Toxic epidermal necrolysis (TEN) and Stevens-Johnson Syndrome (SJS) are rare, acute, life-threatening dermatologic disorders involving the skin and mucous membranes. Research into these conditions is hampered by a lack of standardization o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0fbd2d2259783a3ced11cbfbf836a70
https://pubmed.ncbi.nlm.nih.gov/28658486
https://pubmed.ncbi.nlm.nih.gov/28658486
Publikováno v:
Arthritis & Rheumatism. 62:2517-2524
Objective Malignancies reported in children using tumor necrosis factor α (TNFα) blockers have raised concerns of a potential increased risk. This study was undertaken to investigate postmarketing reports of malignancy in children treated with TNF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8dea0216b678911d9848f84dbd46c84
https://doi.org/10.1002/art.27511
https://doi.org/10.1002/art.27511
Autor:
Andy Stergachis, David J. Graham, Lois La Grenade, Margaret Burgess, Stephanie D. Schech, K. Arnold Chan, Deborah Shatin, Richard Platt, Judy A. Staffa, Susan E. Andrade, David K. Blough
Publikováno v:
Pharmacoepidemiology and Drug Safety. 16:352-358
Purpose To identify and characterize risk factors for rhabdomyolysis in patients prescribed statin monotherapy or statin plus fibrate therapy. Methods A nested case-control study was conducted within a cohort of 252 460 new users of lipid-lowering me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fa01ddda51097d415beadb9b5e53991
https://doi.org/10.1002/pds.1287
https://doi.org/10.1002/pds.1287